Pitney Bowes vs NCR Voyix
PBI and VYX side by side, both in computer and office equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PBI and VYX compare
Pitney Bowes is the larger company, worth 1.5 times as much as NCR Voyix ($2.0B against $1.3B).
On earnings, Pitney Bowes is cheaper: it trades at 11.7× trailing earnings, against 26.4× for NCR Voyix.
Pitney Bowes grew revenue faster over the last twelve months (−3.5% versus −4.8% for NCR Voyix).
Pitney Bowes keeps more of each dollar of sales as profit, with a net margin of 10.1% compared with 3.0% at NCR Voyix.
Pitney Bowes pays a dividend yielding 1.9%; NCR Voyix does not pay one.
Pitney Bowes scores higher on the StockData Score (13 against 7 for NCR Voyix), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PBI | VYX |
|---|---|---|
| Size and price | ||
| Market cap | $2.0B | $1.3B |
| Share price | $15.10 | $9.76 |
| Change, 1 year | 64.7% | −9.5% |
| Change, 5 years | 111% | −75.9% |
| Beta (5Y) | 0.65 | 1.31 |
| Employees | 6,600 | 14K |
| StockData Score | ||
| Total score | 13 (better) | 7 |
| Valuation score | 5 (better) | 4 |
| Growth score | 2 (better) | 0 |
| Performance score | 2 (better) | 1 |
| Health score | 1 | 2 (better) |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 11.7× (better) | 26.4× |
| P/S | 1.1× | 0.5× (better) |
| P/B | – | 1.5× |
| EV/EBITDA | – | 9.0× |
| P/FCF | 4.1× | – |
| PEG | 0.20 | – |
| FCF yield | 24.7% (better) | −2.1% |
| Fair value | $23.54 | $14.73 |
| Margin of safety | 35.9% (better) | 33.8% |
| Growth | ||
| Revenue growth (TTM) | −3.5% (better) | −4.8% |
| Revenue growth, 5Y average | −11.8% (better) | −15.4% |
| Net income growth (TTM) | 135% (better) | −92.8% |
| EPS growth (TTM) | 187% (better) | −94.8% |
| Profitability | ||
| Operating margin | – | 1.1% |
| Net margin | 10.1% (better) | 3.0% |
| FCF margin | 27.1% (better) | −1.1% |
| Return on equity | – | 8.5% |
| Return on invested capital | – | 1.2% |
| Financial health | ||
| Debt / equity | – | 1.19 |
| Net debt / EBITDA | – | 3.51 |
| Interest coverage | – | 0.4× |
| Current ratio | 0.70 | 1.07 (better) |
| Altman Z-score | 2.04 (better) | 1.20 |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | 1.9% | – |
| Payout ratio | 29.1% | – |
| Years of dividend growth | 1 | – |
| Dividend growth, 5Y average | 8.4% | – |
| Buyback yield | 16.2% (better) | 1.9% |
| Shareholder yield | 18.2% (better) | 1.9% |
| Ownership | ||
| Held by institutions | 89.9% | 117% |
| Held by insiders | 5.6% | 0.79% |
| Insider net buying, 12 months | −$92.3M | −$105K (better) |
| Short interest, % of float | 14.9% | – |
Go deeper
- PBI stock overview
- PBI income statement
- PBI valuation and score
- VYX stock overview
- VYX income statement
- VYX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.